USPTO serial 79434178
Reviewed by CopyMark Law Group
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for use in urological, endovascular, cardiovascular, endoscopy and bronchoscopy procedures; medical imaging apparatus; surgical apparatus and instruments for medical, dental or veterinary use; surgical devices and instruments; endoprostheses and stents; medical devices that facilitate the delivery of endoprostheses and stents in the nature of medical and surgical apparatus and instruments for use in implantation of endoprostheses and stent delivery systems; medical devices for use in peripheral vascular procedures. | ACTIVE | — |
| 042 | Product design of medical apparatus and devices; Product design and development of medical technology; design and development of computer software for use with medical apparatus, medical devices and medical technology; Product design and development of medical diagnostic apparatus; software design and development services; design and development of computer hardware and software for use in the field of medicine; software as a service (SaaS) services featuring software for real-time processing, enhancement, and visualisation of medical images for clinical use; software as a service (SaaS) services featuring software for processing, visualising, and managing medical imaging data; research, design and development of software for data management; scientific and medical product research and development services; clinical research in the field of urology, endoprostheses and stent delivery systems and medical research services; Medical and scientific research, namely, conducting clinical research trials for others; technological services, namely, conducting of feasibility studies in the field of new technologies and product research and design relating thereto; design and development of computer hardware and software; software development in particular for clinical and practice management software for general practitioners and specialists; information technology support services being computer programming and software installation, and repair and maintenance services of computer software, in particular to medical practices, and to medical, health, allied health practitioners and clinics and laboratories | ACTIVE | — |
| 044 | Health care services; medical information services; medical services; surgical services, namely, surgery; medical treatment services, namely, medical treatment of urological disorders, cardiovascular disorders, lung disorders, gastrointestinal disorders, kidney stones and urinary tract obstruction. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 1, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 19, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 19, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 19, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 28, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 28, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 24, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |